EarningsQ4 2024 Earnings Report

Valerio Therapeutics (C4X) Q4 2024 Earnings Report

0 Followers

DE:C4X Q4 2024 EPS Results

Actual EPS>-€0.01

Consensus EPS―

Beat/Miss―

One Year Ago EPS-€0.07

Actual Revenue€126.00K

Expected Revenue―

Beat/Miss―

YoY Revenue Growth-93.00%

QuarterQ4 2024

Date07/09/2025

TimeTBA

Conference CallWednesday, July 9, 2025

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 29, 2025	2025 (Q2)	- / -	-0.067	―
Jul 09, 2025	2024 (Q4)	- / >-0.01	-0.067	98.51% (+0.07)
Sep 30, 2024	2024 (Q2)	- / -0.07	-0.1	33.00% (+0.03)
Apr 30, 2024	2023 (Q4)	- / -0.06	-0.073	23.29% (+0.02)
Sep 28, 2023	2023 (Q2)	- / -0.10	-0.11	9.09% (<+0.01)
Apr 24, 2023	2022 (Q4)	- / -0.07	-0.013	-461.54% (-0.06)
Sep 13, 2022	2022 (Q2)	- / -0.11	-0.056	-96.43% (-0.05)
Apr 06, 2022	2021 (Q4)	- / -0.01	-0.05	74.00% (+0.04)
Jul 29, 2021	2021 (Q2)	- / -0.06	0.064	-187.50% (-0.12)
Apr 21, 2021	2020 (Q4)	- / -0.05	-0.411	87.83% (+0.36)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed